Factors Affecting Minority Enrollment in Parkinson’s Disease Genetic Testing (P11-3.002)

Sarah Marmol(University of Miami), Jason Margolesky(University of Miami), Lucila Hernández(University of Miami), Danielle S. Shpiner(University of Miami), Silvia Vargas(University of Miami), Ihtsham Haq(University of Florida), Matthew Feldman(University of Miami), Carlos Singer(University of Miami Health System), Henry Moore(University of Miami), Claudia Cano(University of Miami), Corneliu Luca(University of Miami Health System)

Neurology

April 9, 2024

10.1212/wnl.0000000000204599

Cited by 0

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

|JAMA|2016|397

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

|Sleep Medicine|2013|391

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

|Sleep Medicine|2013|238

Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

|The Lancet Neurology|2020|155

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

|Neurology|2016|137